Illumina, a sequencing giant, has been formally ordered by the EU to undo its $7 billion acquisition of cancer-test provider Grail. The EU regulators are demanding that Illumina divest Grail after completing the deal without permission. This comes after EU merger watchdogs threatened to order Illumina to sell Grail, a move that would undo the $7 billion acquisition. Illumina has been given a year to divest Grail if it does not win the challenge in the EU court.
European regulators detailed their demands that Illumina divest the cancer diagnostics firm Grail, the latest fallout from the sequencing giant’s troubled 2021 acquisition. https://t.co/RTxzDshDjl
Illumina to divest Grail within a year if it does not win challenge in EU court https://t.co/1DkjMj8whw https://t.co/fEOUrlmjkv
Illumina ordered by European Commission to unwind $8 billion Grail deal https://t.co/qYbZ0vwnCr
EU orders Illumina to divest cancer diagnostics firm Grail. https://t.co/t1C11xIvX6
Illumina ordered by European Commission to unwind $8 billion Grail deal https://t.co/0FpyqBoK0n
Illumina was formally ordered to undo its $7 billion acquisition of cancer-test provider Grail as the EU ramped up a legal fight over a deal the firms completed without its permission https://t.co/DZ36JTP7Pb via @business
The EU Orders Illumina to Divest Grail. Get the scoop and what Illumina could do from now on at the site that Rhymes with Haystack, two-clicks away at https://t.co/FDTWkeV9n5
Illumina was formally ordered to undo its $7 billion acquisition of cancer-test provider Grail as the EU ramped up a legal fight over a deal the firms completed without its permission https://t.co/HPVpwBPOJ2
Illumina ordered by EU antitrust regulators to sell Grail https://t.co/GlM5fxVKbg https://t.co/nHnhqK9WyM
Illumina to divest cancer test maker Grail if it loses US or EU court appeal https://t.co/IRVFzFXrbz https://t.co/Fr8JCkHF5f
Illumina to get EU order on Thursday to divest Grail, source says https://t.co/VVrCBkhXJu https://t.co/6HWRlsxARA
EU merger watchdogs are poised to deliver on their threat to order Illumina to sell cancer-test provider Grail, undoing a $7 billion acquisition https://t.co/a1hzNdAwwl
EU regulatory order for Illumina to sell Grail could come next week - FT https://t.co/XUyfhNaLTz https://t.co/e04S87a8BW